Literature DB >> 34596688

Bone marrow biopsy in PCNSL: Relevant or redundant?

Tejpal Gupta1, Jifmi Jose Manjali1, Nilendu Purandare2, Bhausaheb Bagal3.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34596688      PMCID： PMC8643457          DOI： 10.1093/neuonc/noab185

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   13.029


× No keyword cloud information.
  6 in total

Review 1.  FDG PET/CT for the detection of bone marrow involvement in diffuse large B-cell lymphoma: systematic review and meta-analysis.

Authors:  Hugo J A Adams; Thomas C Kwee; Bart de Keizer; Rob Fijnheer; John M H de Klerk; Rutger A J Nievelstein
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-11-27       Impact factor: 9.236

2.  A significant proportion of patients with primary central nervous system lymphoma harbor clonal bone marrow B-cells.

Authors:  Anna Brandt; Jakob Matschke; Wilfried Fehrle; Lisa von Wenserski; Carsten Bokemeyer; Gerald Illerhaus; Mascha Binder
Journal:  Leuk Lymphoma       Date:  2018-07-22

3.  Diagnostic Yield of Extensive Systemic Staging Including Whole-body 18F-fluoro-deoxy-glucose Positron Emission Tomography With or Without Computed Tomography in Patients With Primary Central Nervous System Lymphoma: Systematic Review and Meta-analysis.

Authors:  Tejpal Gupta; Jifmi Jose Manjali; Sadhana Kannan; Nilendu Purandare; Venkatesh Rangarajan
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2020-07-06

4.  FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: results from the prospective, multicenter PETAL and OPTIMAL>60 trials.

Authors:  Dominic Kaddu-Mulindwa; Bettina Altmann; Viola Poeschel; Dirk Hellwig; Gerhard Held; Stephanie Angel; Stephan Stilgenbauer; Lorenz Thurner; Moritz Bewarder; Maren Schwier; Michael Pfreundschuh; Markus Löffler; Karin Menhart; Jirka Grosse; Marita Ziepert; Ken Herrmann; Ulrich Dührsen; Andreas Hüttmann; Francesco Barbato
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-04-29       Impact factor: 9.236

5.  The value of bone marrow biopsy for staging of patients with primary CNS lymphoma.

Authors:  Michelle Margold; Sabine Seidel; Thomas Kowalski; Swetlana Ladigan-Badura; Alexander Baraniskin; Roland Schroers; Anna Verena Frey; Ingo G H Schmidt-Wolf; Ulrich Herrlinger; Agnieszka Korfel; Uwe Schlegel
Journal:  Neuro Oncol       Date:  2021-12-01       Impact factor: 12.300

6.  Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG).

Authors:  Ramon F Barajas; Letterio S Politi; Nicoletta Anzalone; Heiko Schöder; Christopher P Fox; Jerrold L Boxerman; Timothy J Kaufmann; C Chad Quarles; Benjamin M Ellingson; Dorothee Auer; Ovidiu C Andronesi; Andres J M Ferreri; Maciej M Mrugala; Christian Grommes; Edward A Neuwelt; Prakash Ambady; James L Rubenstein; Gerald Illerhaus; Motoo Nagane; Tracy T Batchelor; Leland S Hu
Journal:  Neuro Oncol       Date:  2021-07-01       Impact factor: 12.300
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.